134 related articles for article (PubMed ID: 1371561)
1. The predictive significance of substaging stage A prostate cancer (A1 versus A2) for volume and grade of total cancer in the prostate.
Voges GE; McNeal JE; Redwine EA; Freiha FS; Stamey TA
J Urol; 1992 Mar; 147(3 Pt 2):858-63. PubMed ID: 1371561
[TBL] [Abstract][Full Text] [Related]
2. [Incidental prostate cancer: volume, location and degree of differentiation of the tumor in the radical prostatectomy specimen and value of subclassification to stage A1 and A2].
Voges GE; McNeal JE; Stamey TA
Urologe A; 1991 Nov; 30(6):401-9. PubMed ID: 1722922
[TBL] [Abstract][Full Text] [Related]
3. The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
Carter HB; Partin AW; Epstein JI; Chan DW; Walsh PC
J Urol; 1990 Nov; 144(5):1167-70; discussion 1170-1. PubMed ID: 1700143
[TBL] [Abstract][Full Text] [Related]
4. The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer.
Greene DR; Egawa S; Neerhut G; Flanagan W; Wheeler TM; Scardino PT
J Urol; 1991 Feb; 145(2):324-8; discussion 328-9. PubMed ID: 1988723
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
Epstein JI; Walsh PC; Brendler CB
J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
[TBL] [Abstract][Full Text] [Related]
6. Transrectal ultrasonography in stage A prostate cancer: detection of residual tumor after transurethral resection of prostate.
Egawa S; Greene DR; Flanagan WF; Wheeler TM; Scardino PT
J Urol; 1991 Aug; 146(2):366-71. PubMed ID: 1856933
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
[TBL] [Abstract][Full Text] [Related]
8. Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease.
Larsen MP; Carter HB; Epstein JI
J Urol; 1991 Oct; 146(4):1059-63. PubMed ID: 1895422
[TBL] [Abstract][Full Text] [Related]
9. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
[TBL] [Abstract][Full Text] [Related]
10. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.
Noguchi M; Stamey TA; Neal JE; Yemoto CE
J Urol; 2000 Jun; 163(6):1751-5. PubMed ID: 10799175
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.
Stamey TA; Yemoto CM; McNeal JE; Sigal BM; Johnstone IM
J Urol; 2000 Apr; 163(4):1155-60. PubMed ID: 10737486
[TBL] [Abstract][Full Text] [Related]
12. Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view.
Elgamal AA; Van Poppel HP; Van de Voorde WM; Van Dorpe JA; Oyen RH; Baert LV
J Urol; 1997 Jan; 157(1):244-50. PubMed ID: 8976263
[TBL] [Abstract][Full Text] [Related]
13. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
16. The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer.
Epstein JI; Oesterling JE; Walsh PC
J Urol; 1988 May; 139(5):975-9. PubMed ID: 3361675
[TBL] [Abstract][Full Text] [Related]
17. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of the individual prostate cancer focus.
Greene DR; Wheeler TM
Cancer Invest; 1994; 12(4):425-37. PubMed ID: 8032966
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml.
Zlotta AR; Djavan B; Petein M; Susani M; Marberger M; Schulman CC
J Urol; 1998 Dec; 160(6 Pt 1):2089-95. PubMed ID: 9817330
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
Douglas TH; Morgan TO; McLeod DG; Moul JW; Murphy GP; Barren R; Sesterhenn IA; Mostofi FK
Cancer; 1997 Jul; 80(1):107-14. PubMed ID: 9210715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
